Cargando…
Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer
Chronic obstructive pulmonary disease (COPD) may coexist with lung cancer, but the impact on prognosis is uncertain. Moreover, it is unclear whether pharmacological treatment for COPD improves the patient’s prognosis. We retrospectively investigated patients with advanced non-small-cell lung cancer...
Autores principales: | Ajimizu, Hitomi, Ozasa, Hiroaki, Sato, Susumu, Funazo, Tomoko, Sakamori, Yuichi, Nomizo, Takashi, Kuninaga, Kiyomitsu, Ogimoto, Tatsuya, Hosoya, Kazutaka, Yamazoe, Masatoshi, Tsuji, Takahiro, Yoshida, Hironori, Itotani, Ryo, Ueno, Kentaro, Kim, Young Hak, Muro, Shigeo, Hirai, Toyohiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654854/ https://www.ncbi.nlm.nih.gov/pubmed/34880386 http://dx.doi.org/10.1038/s41598-021-03139-5 |
Ejemplares similares
-
Author Correction: Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer
por: Ajimizu, Hitomi, et al.
Publicado: (2023) -
Yes‐associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1‐rearranged lung cancer
por: Yamazoe, Masatoshi, et al.
Publicado: (2022) -
CD47 polymorphism for predicting nivolumab benefit in patients with advanced non‑small‑cell lung cancer
por: Ogimoto, Tatsuya, et al.
Publicado: (2023) -
Sarcomatoid malignant pleural mesothelioma treated with nivolumab: A case series
por: Hashimoto, Kentaro, et al.
Publicado: (2022) -
MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-X(L) expression
por: Yasuda, Yuto, et al.
Publicado: (2020)